The Combination of Ribavirin and Peginterferon Is Superior to Peginterferon and Placebo for Children and Adolescents With Chronic Hepatitis C

This publication has 34 references indexed in Scilit:

• Ophthalmologic Complications in Children With Chronic Hepatitis C Treated With Pegylated Interferon
  Journal of Pediatric Gastroenterology and Nutrition, 2010
• Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Treatment of Hepatitis C Infection
  New England Journal of Medicine, 2009
• Diagnosis, management, and treatment of hepatitis C: An update # † ‡
  Hepatology, 2009
• Impact of Hepatitis C Virus Infection on Children and Their Caregivers: Quality of Life, Cognitive, and Emotional Outcomes
  Journal of Pediatric Gastroenterology and Nutrition, 2009
• Pathology of chronic hepatitis C in children: Liver biopsy findings in the Peds-C Trial
  Hepatology, 2008
• Efficacy and Safety of Peginterferon-α2b and Ribavirin Combination Therapy in Children With Chronic Hepatitis C Infection
  The Pediatric Infectious Disease Journal, 2008
• The burden of hepatitis C virus infection in children: Estimated direct medical costs over a 10-year period
  The Journal of Pediatrics, 2006
• Understanding social stigma in women with hepatitis C
  Nursing Standard, 2004
• The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994
  New England Journal of Medicine, 1999
• Teratogenic effects of ribavirin on hamster and rat embryos
  Teratology, 1978